BioAmber clinches Lanxess funding, partners with NatureWorks to form AmberWorks
February 23, 2012 | Analyst Insight
BioAmber closed a Series C funding round for $30 million, with Lanxess participating in the latter of two tranches with $10 million and joining the BioAmber board. Existing investors Naxos...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.